Recent Advances in Inflammation & Allergy Drug Discovery (RAIADD)

Recent Advances in Inflammation & Allergy Drug Discovery is a quarterly, peer‑reviewed scientific journal published by Bentham Science Publishers that serves as a key platform for the dissemination of cutting‑edge research in inflammation and allergy therapeutics. The journal brings together original research articles, comprehensive reviews and mini‑reviews, letters, clinical case reports, perspectives and themed issues that highlight the latest discoveries and approaches in understanding and addressing inflammatory and allergic conditions. Its multidisciplinary scope includes work on immunological mechanisms, cellular signaling pathways, mediators of inflammation and allergy, immune dysfunction, and translational strategies for diagnosis and treatment. In addition to reporting fundamental biological insights, the journal places strong emphasis on drug discovery and development, including analyses of recent patents and innovations in therapeutic design. The content spans basic mechanistic studies to preclinical and clinical research, providing readers with both depth and breadth in topics such as novel anti‑inflammatory targets, allergy‑modulating therapies, immune regulation and clinical advances. Manuscripts involving herbal or alternative therapies are included when backed by robust clinical evidence, strengthening the journal’s clinical relevance. With indexing in major scientific databases including Scopus, MEDLINE/PubMed and others, Recent Advances in Inflammation & Allergy Drug Discovery supports scientific communication and collaboration among researchers, pharmaceutical innovators and healthcare professionals focused on mitigating inflammatory and allergic diseases worldwide.

Recent Advances in Inflammation & Allergy Drug Discovery (RAIADD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Immunology and Allergy, ystematic reviews and thematic issues focused on inflammation and allergy research, The journal covers all major pharmacological facets of inflammatory and allergic disease mechanisms, immune dysfunction, cellular pathways, clinical implications, as well as the design and discovery of anti‑inflammatory and allergy‑targeted therapeutics , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2772-2708, E-ISSN: 2772-2716, Established: 2021, Impact Factor: 1.1
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE